Antisense compounds, compositions and methods are provided for modulating
the expression of mucin 1, transmembrane. The compositions comprise
antisense compounds, particularly antisense oligonucleotides, targeted to
nucleic acids encoding mucin 1, transmembrane. Methods of using these
compounds for modulation of mucin 1, transmembrane expression and for
treatment of diseases associated with expression of mucin 1, transmembrane
are provided.
